
	2025
	U.S.		International		Consolidated
Revenue	$	502,097	$	65,990	$	568,087
Adjusted cost of sales(a)	113,824		24,855
Adjusted selling expense(b)	152,075		12,687
Adjusted marketing expense(b)	24,922		3,588
Adjusted general and administrative expense(b)	97,497		9,329
Adjusted research and development expense(c)	11,266		41
Adjusted other segment expense(d)	1,546		180
Adjusted EBITDA	100,967		15,310		116,277
Reconciliation to income before income taxes
Interest expense, net					(26,486)
Depreciation and amortization					(47,011)
Shareholder litigation costs					(51)
Restructuring costs					(2,235)
Equity-based compensation					(12,673)
Debt refinancing					(902)
Loss on extinguishment					(326)
Loss on disposal of a business					(81)
Other items(e)					(803)
Income before income taxes					$	25,709


	2024
	U.S.		International		Consolidated
Revenue	$	506,809	$	66,471	$	573,280
Adjusted cost of sales(a)	118,985		24,188
Adjusted selling expense(b)	157,789		11,233
Adjusted marketing expense(b)	24,235		3,004
Adjusted general and administrative expense(b)	97,592		14,949
Adjusted research and development expense(c)	13,139		41
Adjusted other segment income(d)	(352)		(405)
Adjusted EBITDA	95,421		13,461		108,882
Reconciliation to loss before income taxes
Interest expense, net					(38,792)
Depreciation and amortization					(49,555)
Acquisition and related costs					(1,339)
Shareholder litigation costs					(13,802)
Restructuring costs					57
Equity-based compensation					(13,274)
Debt refinancing					(351)
Impairments of assets					(36,357)
Loss on disposal of a business					(292)
Other items(e)					(7,519)
Loss before income taxes					$	(52,342)


	2023
	U.S.		International		Consolidated
Revenue	$	449,860	$	62,485	$	512,345
Adjusted cost of sales(a)	109,889		25,760
Adjusted selling expense(b)	140,278		11,908
Adjusted marketing expense(b)	24,401		2,655
Adjusted general and administrative expense(b)	86,108		12,285
Adjusted research and development expense(c)	11,458		31
Adjusted other segment income(d)	(942)		(348)
Adjusted EBITDA	78,668		10,194		88,862
Reconciliation to loss before income taxes
Interest expense, net					(40,676)
Depreciation and amortization					(57,365)
Acquisition and related costs					(5,694)
Restructuring and succession charges					(2,331)
Equity-based compensation					(2,722)
Debt refinancing					(7,291)
Impairment of assets					(78,615)
Loss on disposal of a business					(1,539)
Other items(e)					(13,740)
Loss before income taxes					$	(121,111)

(b)Adjusted selling, general and administrative expense used in the calculation of segment Adjusted EBITDA excludes certain acquisition and related costs, shareholder litigation costs, certain restructuring and succession charges, asset impairments, debt refinancing, equity-based compensation expense and other segment items—charges associated with strategic transactions, such as potential divestitures and a transformative project to redesign systems and information processing.

(c)Adjusted research and development expense used in calculating segment Adjusted EBITDA excludes depreciation and amortization, equity-based compensation expense.

(d)Adjusted other segment expense (income) primarily consists of foreign currency transaction and remeasurement gains and losses and other certain nonrecurring items.

(e)During the year ended December 31, 2025, other items primarily consisted of expenses related to the divestiture of the Advanced Rehabilitation Business, which was completed on December 31, 2024.

During the year ended December 31, 2024, other items primarily consisted of divestiture costs related to the Advanced Rehabilitation Business, strategic transaction costs and transformative project costs.

During the year ended December 31, 2023, other items mostly consisted of strategic transaction costs, transformative project costs, transition and severance costs and expenses related to the discontinuance of MOTYS.